SPC393
Roxadustat
Status:
UmsóknApplication date:
16.6.2022Application published:
15.7.2022
Max expiry date:
18.8.2036Medicine name:
EvrenzoMedicine for children:
No
Timeline
Today
16.6.2022Application
15.7.2022Publication
18.8.2036Expires
Marketing license
IS authorization number:
EU/1/21/1574/001; EU/1/21/1574/002; EU/1/21/1574/003; EU/1/21/1574/004; EU/1/21/1574/005Date:
30.8.2021
Foreign authorization number:
EU/1/21/1574Date:
18.8.2021
Owner
Name:
Fibrogen, Inc.Address:
409 Illinois Street, San Francisco, CA US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP3470397